相关实验视频

Updated: Jul 4, 2025

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Published on: February 13, 2018

从小纤维神经病变区分纤维肌痛综合征:一个临床指南

Sarah Jänsch¹, Dimitar Evdokimov¹, Nadine Egenolf¹

¹Department of Neurology, University Hospital of Würzburg, Würzburg, Germany. Meyer zu Altenschildesche is now with the Department of Dermatology, University Hospital Leipzig, Leipzig, Germany.

|January 29, 2024

概括

纤维肌痛综合征 (FMS) 和小纤维神经病变 (SFN) 是不同的疼痛状况. 区分FMS和SFN依赖于详细的病史,症状分析和特定的小纤维测试,以准确诊断和治疗.

科学领域:

神经学神经学
疼痛医学医学疼痛医学
医学诊断医学诊断医学诊断

背景情况:

纤维肌痛综合征 (FMS) 和小纤维神经病变 (SFN) 是不同的慢性疼痛疾病.
它们的重叠症状带来了诊断挑战,需要明确区分才能有效治疗.

研究的目的:

调查临床特征区分女性与FMS和SFN.
确定FMS和SFN之间的差异诊断的临床适用参数.

主要方法:

对158名患有FMS和53名患有SFN的妇女的医疗记录进行了回顾性分析.
评估疼痛史,伴随症状,并发症和治疗反应.
对标准化疼痛,抑郁,焦虑问卷和小纤维测试结果的分析.

主要成果:

FMS患者在发病时更年轻,报告疼痛强度更高,普遍疼痛与相关的肠道/睡眠问题.
SFN患者经历了麻醉,麻木和葡萄糖代谢受损.
这两种情况都显示出小纤维病理,但FMS具有近端皮肤变质和较高的角膜神经密度,而SFN则显示出降低了感冒检测和延长了A-delta延迟.

结论:

FMS和SFN表现出显著的临床和诊断差异.
详细的患者病史,葡萄糖代谢评估和差异小纤维检测对于准确的诊断至关重要.
改善差异化为FMS和SFN患者提供了有针对性的治疗策略.

关键词:

临床表现型临床表现型差异诊断是一种差异诊断.纤维肌痛综合征纤维肌痛综合征疼痛模式是一种疼痛模式.小纤维神经病变小纤维神经病变

更多相关视频

Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay

Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay

Published on: June 25, 2019

Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research

Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research

Published on: January 5, 2024

相关概念视频

Ultrasound II: Endoscopic Ultrasound and FibroScan

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):

Myasthenia Gravis: Diagnostic Tests

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...